Deligoparin sodium

Drug Profile

Deligoparin sodium

Alternative Names: OP 2000

Latest Information Update: 20 Sep 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Opocrin
  • Class Anti-inflammatories; Anticoagulants; Antithrombotics; Low molecular weight heparins
  • Mechanism of Action Factor Xa inhibitors; Thrombin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Ulcerative colitis; Unstable angina pectoris

Most Recent Events

  • 17 Sep 2002 Discontinued - Phase-III for Ulcerative colitis in USA (SC)
  • 29 Aug 2002 Incara has completed patient enrolment in its phase II/III trial of deligoparin for the treatment of ulcerative colitis
  • 20 Mar 2002 A study has been added to the Inflammatory Bowel Disorders therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top